FOXM1 was demonstrated to be necessary and sufficient to cause the progression of lung adenomas into invasive mucinous adenocarcinomas in vivo by activating AGR2 (Milewski et al., 2017). Here, AGR2 is linked to mucinous adenocarcinoma.